Yonkenafil treatment in streptozotocin injection (i.c.v.)rat model of AD [33, 37] and mirodenafil administration in APP-C105 Tg AD mice [18] also showed amelioration of cognitive deficits. The gene discussed is APP; the disease is Alzheimer disease.